BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25052951)

  • 1. Response to "toward personalized sexual medicine: where is the evidence?".
    Tuiten A; Bloemers J; van Rooij K; Poels S; Gerritsen J; van Ham D; de Leede L; Everaerd W
    J Sex Med; 2014 Sep; 11(9):2359-63. PubMed ID: 25052951
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward personalized sexual medicine: where is the evidence?
    Leusink P; Boeke AJ; Laan E
    J Sex Med; 2014 Sep; 11(9):2357-8. PubMed ID: 24964228
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
    van Rooij K; Poels S; Bloemers J; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):824-37. PubMed ID: 23130675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
    Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin (1A) receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary study.
    van Rooij K; Poels S; Worst P; Bloemers J; Koppeschaar H; Goldstein A; Olivier B; Tuiten A
    Eur J Pharmacol; 2015 Apr; 753():246-51. PubMed ID: 25460030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In response. Effects of testosterone replacement on response to sildenafil citrate.
    Spitzer M; Basaria S; Travison TG; Bhasin S
    Ann Intern Med; 2013 Apr; 158(7):570-1. PubMed ID: 23546578
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of testosterone replacement on response to sildenafil citrate.
    Aversa A; Jannini EA; Maggi M; Lenzi A
    Ann Intern Med; 2013 Apr; 158(7):569-70. PubMed ID: 23546577
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of testosterone replacement on response to sildenafil citrate.
    Seftel AD; Hackett G
    Ann Intern Med; 2013 Apr; 158(7):569. PubMed ID: 23546576
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of testosterone replacement on response to sildenafil citrate.
    Smoger S
    Ann Intern Med; 2013 Apr; 158(7):569. PubMed ID: 23546575
    [No Abstract]   [Full Text] [Related]  

  • 10. [Not Available].
    Füessl HS
    MMW Fortschr Med; 2013 May; 155(10):33. PubMed ID: 23930412
    [No Abstract]   [Full Text] [Related]  

  • 11. Summary for patients. Effect of testosterone on response to sildenafil in men with erectile dysfunction.
    Ann Intern Med; 2012 Nov; 157(10):I-18. PubMed ID: 23165675
    [No Abstract]   [Full Text] [Related]  

  • 12. Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial.
    Tuiten A; Michiels F; Böcker KB; Höhle D; van Honk J; de Lange RP; van Rooij K; Kessels R; Bloemers J; Gerritsen J; Janssen P; de Leede L; Meyer JJ; Everaerd W; Frijlink HW; Koppeschaar HP; Olivier B; Pfaus JG
    Womens Health (Lond); 2018; 14():1745506518788970. PubMed ID: 30016917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for female sexual dysfunction.
    Med Lett Drugs Ther; 2007 Apr; 49(1259):33-5. PubMed ID: 17450112
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.
    Reis SL; Abdo CH
    Clinics (Sao Paulo); 2014; 69(4):294-303. PubMed ID: 24714838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Inquiry: which treatments help women with reduced libido?
    Hobbs K; Handler L
    J Fam Pract; 2013 Feb; 62(2):102-3. PubMed ID: 23405381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
    Spitzer M; Basaria S; Travison TG; Davda MN; Paley A; Cohen B; Mazer NA; Knapp PE; Hanka S; Lakshman KM; Ulloor J; Zhang A; Orwoll K; Eder R; Collins L; Mohammed N; Rosen RC; DeRogatis L; Bhasin S
    Ann Intern Med; 2012 Nov; 157(10):681-91. PubMed ID: 23165659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder.
    Bloemers J; van Rooij K; Poels S; Goldstein I; Everaerd W; Koppeschaar H; Chivers M; Gerritsen J; van Ham D; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):791-809. PubMed ID: 23130782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction.
    Morales A
    J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738
    [No Abstract]   [Full Text] [Related]  

  • 19. Two novel combined drug treatments for women with hypoactive sexual desire disorder.
    Poels S; Bloemers J; van Rooij K; Koppeschaar H; Olivier B; Tuiten A
    Pharmacol Biochem Behav; 2014 Jun; 121():71-9. PubMed ID: 24534417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consultation corner. The latest on female sexual health.
    DeRogatis LR
    Johns Hopkins Med Lett Health After 50; 2010 Nov; 22(9):6-7. PubMed ID: 21066837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.